Evidence map›Paper›PMID 38324610›Full record

ArticlePLOS global public health2024

Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru.

Amanda M Biewer, Christine Tzelios, Karen Tintaya, Betsabe Roman, Shelley Hurwitz, Courtney M Yuen, Carole D Mitnick, Edward Nardell, Leonid Lecca, Dylan B Tierney and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Amanda M BiewerBeth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-7113-2885
Christine TzeliosHarvard Medical School, Boston, Massachusetts, United States of America.
Karen TintayaSocios en Salud, Lima, Peru.
Betsabe RomanSocios en Salud, Lima, Peru.ORCID https://orcid.org/0000-0002-4936-9736
Shelley HurwitzHarvard Medical School, Boston, Massachusetts, United States of America.
Courtney M YuenBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Carole D MitnickBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Edward NardellBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Leonid LeccaSocios en Salud, Lima, Peru.
Dylan B TierneyBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-6915-8146
Ruvandhi R NathavitharanaBeth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-3544-5021
Brigham and Women's Hospital · USEsSALUD · PEBeth Israel Deaconess Medical Center · USHarvard University · US

Funding

Finding and Treating Unsuspected and Resistant TB to Reduce Hospital TransmissionR01AI112748 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI NARDELL, EDWARD A., TIERNEY, DYLAN · 2015 to 2019
$3.5M
THWART-TB : Testing Health Workers At Risk to advance our understanding of TB infectionDP2AI176896 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Ruvandhi Nathavitharana · 2023 to 2026
$1.6M
Optimizing Diagnostic Strategies for TB Transmission Control in Health-Care FacilitiesK23AI132648 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NATHAVITHARANA, RUVANDHI · 2018 to 2022
$945k
NIAID NIH HHS DP2 AI176896NIAID NIH HHS K23 AI132648NIAID NIH HHS R01 AI112748
6 · The paper itself

Abstract

Tuberculosis (TB) transmission in healthcare facilities is common in high-incidence countries. Yet, the optimal approach for identifying inpatients who may have TB is unclear. We evaluated the diagnostic accuracy of qXR (Qure.ai, India) computer-aided detection (CAD) software versions 3.0 and 4.0 (v3 and v4) as a triage and screening tool within the FAST (Find cases Actively, Separate safely, and Treat effectively) transmission control strategy. We prospectively enrolled two cohorts of patients admitted to a tertiary hospital in Lima, Peru: one group had cough or TB risk factors (triage) and the other did not report cough or TB risk factors (screening). We evaluated the sensitivity and specificity of qXR for the diagnosis of pulmonary TB using culture and Xpert as primary and secondary reference standards, including stratified analyses based on risk factors. In the triage cohort (n = 387), qXR v4 sensitivity was 0.91 (59/65, 95% CI 0.81-0.97) and specificity was 0.32 (103/322, 95% CI 0.27-0.37) using culture as reference standard. There was no difference in the area under the receiver-operating-characteristic curve (AUC) between qXR v3 and qXR v4 with either a culture or Xpert reference standard. In the screening cohort (n = 191), only one patient had a positive Xpert result, but specificity in this cohort was high (>90%). A high prevalence of radiographic lung abnormalities, most notably opacities (81%), consolidation (62%), or nodules (58%), was detected by qXR on digital CXR images from the triage cohort. qXR had high sensitivity but low specificity as a triage in hospitalized patients with cough or TB risk factors. Screening patients without cough or risk factors in this setting had a low diagnostic yield. These findings further support the need for population and setting-specific thresholds for CAD programs.

Identifiers

PMID38324610
PMCPMC10849246
OpenAlexW4391594719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.